Campuswide survey for December 2015 graduates seeks feedback on ‘first destinations’

The U. of I.’s campuswide outcomes survey is now available for December 2015 graduates earning a bachelor’s degree. Faculty members are asked to encourage graduates to respond to the survey, which asks about employment, continued education and other next steps after graduation. Graduates can access their unique survey links online.

The survey is part of the First Destination Initiative, a collaboration among the Office of the Provost, the Career Center and the Division of Management Information, with essential support provided by additional units. The survey results will be released in spring 2016. More information about the survey is available online.

Twelve Illinois scientists rank among the world’s most influential

CHAMPAIGN, Ill. — Twelve scientists at the University of Illinois Urbana-Champaign have been named to the 2025 Clarivate Analytics Highly Cited Researchers list. The list recognizes researchers and social scientists who have demonstrated exceptional influence, as reflected through their publication of multiple papers frequently cited by their peers during the last decade. The highly cited […]

Engineering A tilted view of miscellaneous of multicolored used batteries.

Study shows new hope for commercially attractive lithium extraction from spent batteries

A new study shows that lithium — a critical element used in rechargeable batteries and susceptible to supply chain disruption — can be recovered from battery waste using an electrochemically driven recovery process. The method has been tested on commonly used types of lithium-containing batteries and demonstrates economic viability with the potential to simplify operations, minimize costs and increase the sustainability and attractiveness of the recovery process for commercial use.

Health and Medicine Research team in the lab.

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy

CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted […]

Read Next

Twelve Illinois scientists rank among the world’s most influential

Study shows new hope for commercially attractive lithium extraction from spent batteries

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy